Healthcare Market Research Reports & Industry Analysis

Healthcare refers to the field associated with maintaining or restoring patients’ health. These days’ Healthcare Industry falls into a lashing of discrete sub-sectors, and ancillary goods and services. Ranging from therapeutic equipment to medicinal drugs, medical tourism to sickness insurance, the Healthcare Market has been one of the most swiftly expanding sectors within the globe’s economic system.

Global Healthcare spending contributes close to 10% to the whole world’s GDP, though it varies noticeably with geography. Thus, the Western world’s average healthcare costs are far greater in contrast to those in the developing economies. North America alone is in charge of circa a half of the world’s overall spending on healthcare services. With budgets curtailments and growing costs, technology advances are increasingly taking a new meaning in the global Healthcare universe.

The research reports offer comprehensive insights into the market sizing, structure and dynamics of the Healthcare Industry based on various geographies, as well as in-depth market segmentation. The research reports incorporated in this Catalogue closely investigate the competition in the Healthcare Market, besides profiling countless market participants. Moreover, tomorrow's healthcare-related challenges are addressed, as well as projections into the future are provided in the research reports.

Publications found: 69,579
Sort by:

Substance P Receptor (Tachykinin Receptor 1 or NK 1 Receptor or NK1R or TACR1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Substance P Receptor (Tachykinin Receptor 1 or NK 1 Receptor or NK1R or TACR1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Substance...

May 2022 52 pages

Surface Protein gp120 Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Surface Protein gp120 Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Surface Protein gp120 Drugs in Development by Therapy Areas and Ind...

May 2022 62 pages

Surgical Wound Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Surgical Wound Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Surgical Wound Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule T...

May 2022 37 pages

Synaptic Functional Regulator FMR1 (Fragile X Mental Retardation Protein 1 or FMRP or FMR1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Synaptic Functional Regulator FMR1 (Fragile X Mental Retardation Protein 1 or FMRP or FMR1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMA...

May 2022 35 pages

Synaptosomal Associated Protein 25 (Synaptosomal Associated 25 kDa Protein or Super Protein or SNAP25) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Synaptosomal Associated Protein 25 (Synaptosomal Associated 25 kDa Protein or Super Protein or SNAP25) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Pl...

May 2022 51 pages

Systemic Candidiasis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Systemic Candidiasis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Systemic Candidiasis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Ke...

May 2022 55 pages

Systemic Idiopathic Juvenile Arthritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Systemic Idiopathic Juvenile Arthritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Systemic Idiopathic Juvenile Arthritis Drugs in Development by Stages, Ta...

May 2022 37 pages

Systemic-Onset Juvenile Idiopathic Arthritis (Still Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Systemic-Onset Juvenile Idiopathic Arthritis (Still Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Systemic-Onset Juvenile Idiopathic Arthritis (Still...

May 2022 54 pages

Systolic Heart Failure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Systolic Heart Failure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Systolic Heart Failure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type an...

May 2022 49 pages

T-Cell Acute Lymphocytic Leukemia (T-Cell Acute Lymphoblastic Leukaemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

T-Cell Acute Lymphocytic Leukemia (T-Cell Acute Lymphoblastic Leukaemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY T-Cell Acute Lymphocytic Leukemia (T-Ce...

May 2022 79 pages

T-Cell Leukemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

T-Cell Leukemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY T-Cell Leukemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players...

May 2022 81 pages

T-Cell Lymphomas Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

T-Cell Lymphomas Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY T-Cell Lymphomas Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Player...

May 2022 263 pages

T Cell Specific Surface Glycoprotein CD28 (TP44 or CD28) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

T Cell Specific Surface Glycoprotein CD28 (TP44 or CD28) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY T Cell Specific Surface Glycopro...

May 2022 58 pages

T Cell Surface Glycoprotein CD3 Epsilon Chain (T Cell Surface Antigen T3-Leu 4 Epsilon Chain or CD3E) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

T Cell Surface Glycoprotein CD3 Epsilon Chain (T Cell Surface Antigen T3-Leu 4 Epsilon Chain or CD3E) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Pla...

May 2022 43 pages

T Cell Surface Glycoprotein CD4 (T Cell Surface Antigen T4-Leu 3 or CD4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

T Cell Surface Glycoprotein CD4 (T Cell Surface Antigen T4-Leu 3 or CD4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY T Cell Surface G...

May 2022 49 pages

T Lymphocyte Activation Antigen CD80 (Activation B7-1 Antigen or CTLA 4 Counter Receptor B7.1 or CD80) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

T Lymphocyte Activation Antigen CD80 (Activation B7-1 Antigen or CTLA 4 Counter Receptor B7.1 or CD80) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Pl...

May 2022 43 pages

TAR DNA Binding Protein 43 (TDP43 or TARDBP) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

TAR DNA Binding Protein 43 (TDP43 or TARDBP) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY TAR DNA Binding Protein 43 (TDP43 or TARDBP)...

May 2022 51 pages

Tauopathies Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Tauopathies Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Tauopathies Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides...

May 2022 69 pages

Tay-Sachs Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Tay-Sachs Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Tay-Sachs Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Play...

May 2022 47 pages

Tenosynovial Giant Cell Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Tenosynovial Giant Cell Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Tenosynovial Giant Cell Tumor Drugs in Development by Stages, Target, MoA, RoA, Mo...

May 2022 42 pages

Testicular Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Testicular Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Testicular Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Play...

May 2022 46 pages

Thioredoxin (Trx or ATL Derived Factor or Surface Associated Sulphydryl Protein or TXN) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Thioredoxin (Trx or ATL Derived Factor or Surface Associated Sulphydryl Protein or TXN) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY T...

May 2022 37 pages

Thromboangiitis Obliterans (Buerger Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Thromboangiitis Obliterans (Buerger Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Thromboangiitis Obliterans (Buerger Disease) Drugs in Development b...

May 2022 37 pages

Thrombocytopenia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Thrombocytopenia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Thrombocytopenia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Player...

May 2022 106 pages

Thrombopoietin Receptor (Myeloproliferative Leukemia Protein or Proto Oncogene c Mpl or CD110 or MPL) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Thrombopoietin Receptor (Myeloproliferative Leukemia Protein or Proto Oncogene c Mpl or CD110 or MPL) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Pla...

May 2022 47 pages

Thrombosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Thrombosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Thrombosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides a...

May 2022 151 pages

Thromboxane A2 Receptor (Prostanoid TP Receptor or TBXA2R) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Thromboxane A2 Receptor (Prostanoid TP Receptor or TBXA2R) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Thromboxane A2 Receptor (Prost...

May 2022 36 pages

Thymic Carcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Thymic Carcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Thymic Carcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Player...

May 2022 70 pages

Thymic Stromal Lymphopoietin (TSLP) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Thymic Stromal Lymphopoietin (TSLP) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Thymic Stromal Lymphopoietin (TSLP) Drugs in Developm...

May 2022 41 pages

Thymidine Kinase (TK or EC 2.7.1.21) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Thymidine Kinase (TK or EC 2.7.1.21) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Thymidine Kinase (TK or EC 2.7.1.21) Drugs in Develo...

May 2022 38 pages

Thymidylate Synthase (TYMS or EC 2.1.1.45) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Thymidylate Synthase (TYMS or EC 2.1.1.45) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Thymidylate Synthase (TYMS or EC 2.1.1.45) Dru...

May 2022 55 pages

Thymoma (Thymic Epithelial Tumor) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Thymoma (Thymic Epithelial Tumor) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Thymoma (Thymic Epithelial Tumor) Drugs in Development by Stages, Target, MoA,...

May 2022 81 pages

Thyrotropin Receptor (Thyroid Stimulating Hormone Receptor or TSHR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Thyrotropin Receptor (Thyroid Stimulating Hormone Receptor or TSHR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Thyrotropin Receptor...

May 2022 35 pages

Tissue Type Plasminogen Activator (t Plasminogen Activator or Alteplase or Reteplase or Plasminogen-Activator Kringle or PLAT or EC 3.4.21.68) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Tissue Type Plasminogen Activator (t Plasminogen Activator or Alteplase or Reteplase or Plasminogen-Activator Kringle or PLAT or EC 3.4.21.68) Drugs in Development by Therapy Areas and Indications, St...

May 2022 39 pages

Toll Like Receptor 2 (Toll-Interleukin 1 Receptor Like Protein 4 or CD282 or TLR2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Toll Like Receptor 2 (Toll-Interleukin 1 Receptor Like Protein 4 or CD282 or TLR2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Toll L...

May 2022 59 pages

Toll Like Receptor 5 (Toll-Interleukin 1 Receptor Like Protein 3 or TLR5) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Toll Like Receptor 5 (Toll-Interleukin 1 Receptor Like Protein 3 or TLR5) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Toll Like Recep...

May 2022 39 pages

Toll Like Receptor 9 (CD289 or TLR9) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Toll Like Receptor 9 (CD289 or TLR9) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Toll Like Receptor 9 (CD289 or TLR9) Drugs in Develo...

May 2022 72 pages

Toll Like Receptor Family (TLR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 3,500.00

Toll Like Receptor Family (TLR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Toll Like Receptor Family (TLR) Drugs in Development by T...

May 2022 227 pages

Tonic-Clonic (Grand Mal) Seizure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Tonic-Clonic (Grand Mal) Seizure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Tonic-Clonic (Grand Mal) Seizure Drugs in Development by Stages, Target, MoA, R...

May 2022 37 pages

TRAF2 and NCK Interacting Protein Kinase (TNIK or EC 2.7.11.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

TRAF2 and NCK Interacting Protein Kinase (TNIK or EC 2.7.11.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY TRAF2 and NCK Interacting...

May 2022 35 pages

Trans Activator Of Transcription (Tat) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Trans Activator Of Transcription (Tat) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Trans Activator Of Transcription (Tat) Drugs in De...

May 2022 36 pages

Transferrin Receptor Protein 1 (T9 or p90 or CD71 or TFRC) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Transferrin Receptor Protein 1 (T9 or p90 or CD71 or TFRC) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Transferrin Receptor Protein 1...

May 2022 40 pages

Transferrin Receptor (TFR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Transferrin Receptor (TFR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Transferrin Receptor (TFR) Drugs in Development by Therapy Are...

May 2022 51 pages

Transformed Mycosis Fungoides Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Transformed Mycosis Fungoides Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Transformed Mycosis Fungoides Drugs in Development by Stages, Target, MoA, RoA, Mo...

May 2022 37 pages

Transforming Growth Factor Beta 3 (TGFB3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Transforming Growth Factor Beta 3 (TGFB3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Transforming Growth Factor Beta 3 (TGFB3) Drugs...

May 2022 37 pages

Transforming Growth Factor Beta (TGFb) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 3,500.00

Transforming Growth Factor Beta (TGFb) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Transforming Growth Factor Beta (TGFb) Drugs in De...

May 2022 141 pages

Transforming Growth Factor (TGF) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 3,500.00

Transforming Growth Factor (TGF) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Transforming Growth Factor (TGF) Drugs in Development by...

May 2022 184 pages

Transitional Cell Carcinoma (Urothelial Cell Carcinoma) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Transitional Cell Carcinoma (Urothelial Cell Carcinoma) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Transitional Cell Carcinoma (Urothelial Cell Carcinoma)...

May 2022 171 pages

Transitional Endoplasmic Reticulum ATPase (Valosin Containing Protein or 15S Mg(2+) ATPase p97 Subunit or VCP or EC 3.6.4.6) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Transitional Endoplasmic Reticulum ATPase (Valosin Containing Protein or 15S Mg(2+) ATPase p97 Subunit or VCP or EC 3.6.4.6) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Mo...

May 2022 36 pages

Transmembrane Protease Serine 2 (Serine Protease 10 or TMPRSS2 or EC 3.4.21.) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Transmembrane Protease Serine 2 (Serine Protease 10 or TMPRSS2 or EC 3.4.21.) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Transmembra...

May 2022 46 pages

Filters

Search

Categories

836
28
208
156
143
133
127
93
65,439
803
718
772
123

Publishers

179
1
239
158
389
103
444
148
425
3
202
3
6
1,620
487
76
123
208
111
25
212
1,049
378
23
40
68
472
277
34
29,954
248
501
3,036
1
1
2
3
16
536
361
1
1,357
1,790
60
1,696
8
8,921
2,212
4,495
321
66
3
36
200
29
29
143
42
83
3
281
85
20
6
43
14
1
178
48
359
36
44
10
11
18
168
323
8
3
18
58
901
6
89
12
24
15
1,285
227
128
386
3
74
10
119
228
46
474
26
133
4

Regions

92
58
45
43
41
35
31
30
30
29
28
28
28
26
16
16
14
12
12
10
10
10
9
8
8
8
7
7
7
7
7
6
6
6
6
6
6
6
6
6
6
6
6
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
790
495
2
2
2
117
194
102
53
23
704
26
136
526
174
623
64,568

Price

Date

Pages

Offers

1
280
1
1